Fadi Haddad, MD

home / authors / fadi-haddad-md

Fadi G. Haddad, MD, is assistant professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston.

Articles

Treatment Failure in CML: Distinguishing Between Disease Resistance and Treatment Intolerance

Fadi Haddad, MD;Hagop Kantarjian, MD

June 13th 2024

Patients with chronic myeloid leukemia can have a near-normal life expectation when treated with BCR::ABL1 tyrosine kinase inhibitors.

Background on the Phase 2 Study of Ponatinib/Blinatumomab in Ph+ ALL

Fadi Haddad, MD

February 21st 2023

Fadi Haddad, MD, discusses the background of a phase 2 study of blinatumomab in combination with ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Updated Findings of Ponatinib/Blinatumomab Combo in Ph+ ALL are Encouraging

Fadi Haddad, MD

November 22nd 2022

Fadi Haddad, MD, discusses the key points from the presentation he gave during the Tenth Annual Meeting of the Society of Hematologic Oncology.